Michael Eagle has been appointed executive chairman ofIntraLuminal Therapeutics(Carlsbad, California). Eagle was vice president, manufacturing for Eli Lilly and Co. from 1993 until his retirement in 2001. IntraLuminal Therapeutics makes the Safe-Cross RF Total Occlusion Crossing System, designed to safely cross total occlusions using optical coherence reflectometry technology and radio frequency energy.

John Sharkey, PhD, has renewed his agreement and will continue as president of Ophthalmic International (Fountain Hills, Arizona), a subsidiary of Coronado Industries. Sharkey, who also serves as Coronado’s director of operations, has been president of Ophthalmic International since October 2004. Ophthalmic International manufactures pneumatic devices for the non-invasive treatment of glaucoma.

• PolyMedica (Woburn, Massachusetts) named Devin Anderson general counsel. Anderson has served as PolyMedica’s associate general counsel since December 2002, as secretary of PolyMedica’s board of directors since June 2003 and as vice president since May 2004. William Eck, currently PolyMedica’s senior vice president, chief of healthcare affairs and general counsel, will be returning to the Greenberg Traurig law firm as a principal shareholder. Eck will continue to represent PolyMedica on healthcare, compliance and legislative matters. With more than 700,000 active patients, PolyMedica calls itself the nation’s largest provider of blood glucose testing supplies and related services to people with diabetes.

Shaun Kirkpatrick has been named president and CEO of Research Corp. Technologies (RCT; Tucson, Arizona). Formerly RCT’s president and chief operating officer, Kirkpatrick succeeds current CEO Gary Munsinger, PhD, who is also chairman of the company’s board of directors. Munsinger will retire from RCT July 1 and will continue as non-executive chairman of the board. RCT is a technology investment and management company that provides early/seed-stage funding and development for promising biomedical companies and technologies originating in universities and research institutions.

Donald Stewart, vice president of finance and administration and CFO of RITA Medical Systems (Fremont, California), will resign from the company to pursue other business interests when a suitable replacement can be found. Stewart will remain active as CFO during the recruiting and transition periods. He joined the company in 2001 as vice president-finance and administration and CFO, and served as interim CEO in 2003. RITA Medical manufactures radiofrequency ablation systems for treating cancerous tumors as well as percutaneous vascular and spinal access systems.